Drug Type Small molecule drug |
Synonyms |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors), IL-1β inhibitors(Interleukin-1 beta inhibitors), IL-6 inhibitors(Interleukin-6 inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroinflammation | Preclinical | CA | 06 May 2024 |